295 results on '"Trupl J"'
Search Results
2. Antibiotic resistance and virulence factors among clinical and food enterococci isolated in Slovakia
3. Toxinogenicity and markers of pathogenicity ofPseudomonas aeruginosa strains isolated from patients with tumor diseases
4. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
5. Nosocomial candidaemias due to species other than Candida albicans in cancer patients: Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution
6. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case-controlled study
7. Predictors of mortality in bacteremic cancer patients: retrospective analysis of 64 deaths occurring among 262 bacteremic episodes
8. Staphylococcal bacteremia in cancer patients: Risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia
9. Invasive mold infections in cancer patients: 5 years' experience withAspergillus, Mucor, Fusarium andAcremonium infections
10. Survey of susceptibility to selected antibiotics ofPseudomonas aeruginosa strains isolated from patients with tumor disease and their relationship to serotype
11. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in central and eastern Europe
12. Activity of telithromycin and seven other agents against 1034 pediatric Streptococcus pneumoniae isolates from ten central and eastern European centers
13. Bacteraemia and Fungaemia During Ofloxacin Prophylaxis in Cancer Patients
14. ETIOLOGY, COST OF ANTIMICROBIAL THERAPY AND OUTCOME IN NEUTROPENIC PATIENTS WHO DEVELOPED BACTEREMIA DURING PROPHYLAXIS WITH OFLOXACIN: A CASE-CONTROL STUDY
15. SUSCEPTIBILITY OF E. COLI ISOLATES FROM BLOOD CULTURES OF CANCER PATIENTS TO CIPROFLOXACIN
16. SUSCEPTIBILITY OF 132 ENTEROCOCCOAL ISOLATES FROM BLOOD CULTURES TO CIPROFLOXACIN, VANCOMYCIN AND TEICOPLANIN
17. ANTIMICROBIAL SUSCEPTIBILITY OF 2846 ORGANISMS ISOLATED FROM BLOODSTREAM INFECTIONS IN A TERTIARY HOSPITAL TO OFLOXACIN BETWEEN 1988–1998
18. Bacteraemia due to vancomycin-resistant enterococci in Slovakia
19. Fungemia in Neonates: Report of 80 Cases From Seven University Hospitals
20. In vitro susceptibility of 90 penicillin-susceptible and-resistant pneumococci to penicillin G, amoxicillin, amoxicillin/clavulanate, cefaclor, cefuroxime, cefpodoxime, cefixime and imipenem
21. In vitro susceptibility of pneumococci to trovafloxacin, penicillin G, and other antimicrobial agents in the Czech Republic and Slovakia
22. Nosocomial bacteremia due to vancomycin-resistantStaphylococcus epidermidis in four patients with cancer, neutropenia, and previous treatment with vancomycin
23. Intramucosal bacteria in colon cancer and their elimination by probiotic strainEnterococcus faecium M-74 with organic selenium
24. Nosocomial bacterial and fungal meningitis in cancer patients
25. Once-Daily Pefloxacin + Teicoplanin vs Netilmicin + Teicoplanin in Empirical Therapy for Fever and Neutropenia
26. Bacteraemia due to penicillin-resistant Streptococcus viridans in cancer patients, before and after prophylaxis with penicillin
27. Ciprofloxacin plus Vancomycin vs Ceftazidime plus Gentamicin in the Treatment of Pneumonia in Granulocytopenic Patients
28. Bacteremia due to teicoplanin-resistant and vancomycin-susceptibleStaphylococcus haemolyticus in seven patients with acute leukemia and neutropenia receiving prophylaxis with ofloxacin
29. Presence of spiral bacteria(“Gastrospirillum hominis”) in the gastric mucosa
30. Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005
31. Staphylococcal bacteremia in cancer patients: risk factors and outcome in 134 episodes prior to and after introduction of quinolones into infection prevention in neutropenia
32. Clinical analysis of 92 patients with Fungaemia - data from national survey in Slovakia
33. Candidosis, aspergillosis and zygomycosis in an oncology department
34. PIN10 ANTIMICROBIAL TREATMENT OF ACUTE OTITIS MEDIA AND ITS PHARMACOECONOMIC ANALYSIS IN SLOVAKIA
35. Prevention of febrile neutropenia in cancer patients by probiotic strain Enterococcus faecium M-74. Phase II study
36. Antimicrobial effects of heptacaine and some intermediary products obtained during its synthesis
37. Susceptibility to Antimicrobial Agents of Stenotrophomonas maltophilia Isolated from Patients with Cancer and Bacteremia
38. Susceptibility of Fungal or Yeast Bloodstream Isolates to Antifungals: Results from a National Study
39. Antibiotic Use and Development of Resistance in Blood Culture Isolates: 8 Years of Experience from a Cancer Referral Center
40. Fungemia in Patients with Solid Tumors
41. Bacteremia Due to CiprofLoxacin-Resistant Pseudomonas Aeruginosain Cancer Patients: Risk Factors for Resistance and Outcome of 25 Episodes. A Case-Control Study
42. Bacteraemia and Fungaemia During Ofloxacin Prophylaxis in Cancer Patients
43. NosocomialCandida kruseiFungemia in Cancer Patients: Report of 10 Cases and Review
44. Association Between Consumption of Antibiotics and Development of Resistance
45. Impact of Ofloxacin Used Prophylactically in Neutropenic Patients on Development of Resistance
46. Bacteremia due to methicillin-resistant staphylococci occurs more frequently in neutropenic patients who received antimicrobial prophylaxis and is associated with higher mortality in comparison to methicillin-sensitive bacteriemia
47. Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome
48. Risk factors and outcome of non-Candida spp. yeasts causing fungaemia in cancer patients: comparison with Candida albicans
49. Nosocomial catheter-associated Flavobacterium odoratum bacteraemia in cancer patients
50. Bacteremia and Fungemia in Pediatric Versus Adult Cancer Patients after Chemotherapy: Comparison of Etiology, Risk Factors and Outcome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.